I don't understand your post. Of course authorized shares are not issued. LP will not issue 900 million shares at once. No one is saying that. Yesterdays dilution took the wind out of the positive ASM sails IMO.
LP said this at ASM
"We also are aware that it’s very typical to need a surge of launch funding, a surge of financing to deal with the surge of costs associated with an initial launch. We very much plan to focus as intensively as possible on non-dilutive structures for that. The two typical structures that we’re familiar with are either royalty-based financing or debt-based structures, non-convertible debt-based structures. Suffice it to say we’re mindful of launch funding needs and focused on non-dilutive approaches.
Then she turns around and dilutes 5 million shares same day. Yes, bills need to be paid. All the moves going forward, testing, applications, building, hiring , etc.. need cash. From the tone of the ASM it looks like no B/O, which means they pay for everything out of NWBO's pocket.
Here is my prediction. SP rises on approval. Thats lasts about a day or 2 as sideline money is used. Then the dilution begins again. As she said, "launch funding". Profits will be put back into company. I am now hoping for 2$ a share and I am out. Will it deliver generational wealth? Probably, but its going to take many years to see that. 2 years for MHRA approval, for 1 type of cancer, even with consultants and a favorable relationship with the UK. Good luck with FDA, no matter what new policies are enacted.
Market Data 
Markets 
AI
